Talcid for acid rebound after stopping long-term PPI therapy
Part of Digestive system clinical trials.
This study tests whether Talcid chewable tablets can relieve the acid reflux symptoms that often happen when you stop taking a long-term daily acid-reducing medicine (like omeprazole). It is for people whose doctor says they no longer need that medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have stopped taking a daily acid-reducing medicine (like omeprazole or pantoprazole) that you used for at least 8 weeks, and your doctor agrees you no longer need it.
- You now have new or worse heartburn, acid reflux, or sour stomach because of stopping the medicine.
- You do not have a severe form of GERD, a stomach ulcer, or a rare condition called Zollinger-Ellison syndrome.
- You are not pregnant, breastfeeding, and do not have severe kidney problems, low phosphate, Alzheimer's disease, or myasthenia gravis.
- You are willing to buy and use Talcid chewable tablets for your symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called budesonide can help people with a type of chronic stomach discomfort that gets worse after meals (functional dyspepsia). If you often feel full or bloated after eating and have had a normal stomach exam, this study may be a good fit for you.
This study tests a new topical treatment for people with chronic heartburn and acid regurgitation who don't have erosions (damage) in their esophagus. The treatment is applied directly to the affected area and may help relieve symptoms without taking daily pills.
This study tests whether it is safe and helpful to reduce or stop daily high-dose heartburn medications (called PPIs) in patients who might not need them anymore. It is for adults who take a strong PPI every day and can communicate in German.
This study tests whether it is safe to stop taking acid-reducing pills (PPIs) for people with inactive IBD. If you have been on a PPI for over 6 months and your IBD is stable, you may be able to join.
This study tests how well omeprazole (a common acid-blocking medicine) works for people with laryngopharyngeal reflux (LPR), a condition where stomach acid irritates the throat. If you have had throat symptoms for more than 8 weeks and are already scheduled for an endoscopy with acid monitoring, you may qualify to see if this medicine helps more than a placebo.
This study tests a new acid-reducing medicine (a potassium-competitive acid blocker) for people with Barrett's esophagus, a condition linked to acid reflux. It aims to see if this new treatment is safe and effective compared to standard proton pump inhibitors, and it might offer a better option for managing the condition.
Hear when a new Gastroesophageal Reflux trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.